-
-
Call more information
660-596-2224 -
Author: Steven L. Shafer, MD, FASA ASA Monitor April 2024, Vol. 88, 1–9. I’ve been formally accused of plagiarism twice. I committed plagiarism last month. I am committing plagiarism in this essay. I plan to plagiarize again next week. Last November, I committed plagiarism on a witness stand. It’s amazing I’m not in jail. I’ve accused […]
Read MoreASA Monitor April 2024, Vol. 88, 14. Clearance for catheter for PAD treatment AngioDynamics has received FDA 510(k) clearance for the Auryon XL Catheter, a 225-cm radial access catheter used with the Auryon Atherectomy System to treat peripheral arterial disease (PAD). PAD affects millions globally, and studies suggest that radial access reduces bleeding and complications compared […]
Read MoreAuthors: Maxime Léger, M.D., Ph.D. et al Anesthesiology April 2024, Vol. 140, 679–689. Background Opioid-free anesthesia is increasingly being adopted to reduce opioid consumption, but its impact on early postoperative recovery after major surgery has not been evaluated in comparative trials. The hypothesis was that an opioid-free anesthesia protocol would enhance the early quality of recovery […]
Read MoreAuthors: Johan Birnefeld, M.D. et al Anesthesiology April 2024, Vol. 140, 669–678. Background Adequate cerebral perfusion is central during general anesthesia. However, perfusion is not readily measured bedside. Clinicians currently rely mainly on mean arterial pressure (MAP) as a surrogate, even though the relationship between blood pressure and cerebral blood flow is not well understood. The […]
Read MoreAuthor: Len Strazewski, AMA Health Care Pulse Report via Linkin AMA survey of 200-plus health systems across U.S. shows which residents are at greatest risk of burnout—and when. Physician burnout is a crisis in medicine and a serious problem for individual doctors, but it can hurt more than the professionals who have followed their […]
Read MoreAuthor: Helen Olkaba, MS ASA Monitor April 2024, Vol. 88, 30. G2211 – Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient’s single, serious condition […]
Read MoreASA Monitor April 2024, Vol. 88, 14. AI digital biomarker for lung fibrosis diagnosis Imvaria Inc. has gained FDA approval for Fibresolve, an AI-driven digital biomarker solution facilitating noninvasive diagnosis of lung fibrosis, notably idiopathic pulmonary fibrosis (IPF). Lung fibrosis is a life-threatening disease, with IPF being particularly devastating. Current therapies are expensive and potentially toxic […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review ASCs are facing major obstacles to securing anesthesia coverage, and the decline in reimbursements is exacerbating the issue. Here are six notes about the decline of reimbursements: 1. The average anesthesia reimbursement rate for 2023 was $21.88, a 5.5% decline from 2019, according to a Jan. 16 blog post from Coronis […]
Read MoreAuthor: Jennifer R. Root, MD, FASA ASA Monitor April 2024, Vol. 88, 32. For most of my career, when I have seen something unusual (like a sneeze under a general anesthetic – I’ve seen it twice now), the only people to discuss it with are your partners. And unless you are in an academic environment, that […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review Raynaldo Ortiz Jr., MD, an anesthesiologist who allegedly injected heart-stopping drugs into IV bags at Baylor Scott & White Surgicare North Dallas, appeared in court ahead of his trial, which is set to begin April 1, according to ABC affiliate WFAA. Dr. Ortiz has been in federal custody since his […]
Read More